Know What's Happening in BioTech
Know What's Happening in BioTech
BioTech Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Researchers at Rockefeller University demonstrated that loss of beige fat in mice triggers hypertension. Mice engineered to lack the beige‑fat regulator PRDM16 develop perivascular fibrosis and heightened sensitivity to angiotensin II. The study identified the secreted enzyme QSOX1 as the key mediator and showed that QSOX1 deletion restores normal vascular function. Parallel human data linking PRDM16 variants to elevated blood pressure suggest the findings are translatable to patients.
Alcon, Aerie Pharmaceuticals, and Avizorex Pharma announced FDA approval of acoltremon (Tryptyr®), the first‑in‑class TRPM8 thermoreceptor agonist for dry eye disease. The ophthalmic solution activates corneal nerves to boost natural tear production, offering a novel mechanism compared with existing anti‑inflammatory...
A research team at Ludwig Maximilian University of Munich has created hybrid polymer nanocarriers combining PLGA and PBAEs to deliver inhalable mRNA vaccines. The system penetrates airway mucus, escapes endosomes, and transfects immune cells more efficiently than existing lipid nanoparticles....
Shanghai‑based Fosun Pharmaceutical is accelerating its transformation from a domestic generic manufacturer into a global innovator. The group has earmarked billions of dollars for overseas R&D hubs, strategic biotech partnerships and a new $2.5 billion bond to fund its expansion. Recent...
OpenAI wrote the lead check in Merge Labs’ $250 million seed round, valuing the Sam Altman‑backed brain‑computer interface startup at $850 million. Merge Labs aims to create non‑invasive BCIs that use molecular carriers and ultrasound to communicate with neurons, positioning itself as...
Alfasigma has secured worldwide rights to a parenteral formulation of adibelivir for the treatment of HSV encephalitis, an ultra‑rare neurological condition. The agreement positions Alfasigma to commercialize the therapy across major markets. Meanwhile, BridgeBio announced a $550 million senior unsecured note...
Boston Scientific announced a $14.5 billion acquisition of Penumbra, paying $374 per share in cash and stock. Penumbra’s portfolio of clot‑removal and embolization devices will broaden Boston Scientific’s reach into fast‑growing thrombectomy and vascular bleeding markets. The deal values Penumbra at...
The latest Bioengineer roundup highlights several cutting‑edge chemical and biological advances. A thermal [2+2] cycloaddition delivers gem‑difluoro bicycloalkanes, while cobalt‑catalyzed siloxycarbene chemistry enables efficient thioester coupling. Researchers also report a homologative difunctionalization method that broadens alkene functionalization, a biocompatible ligand...
Scientists at the Qingdao Institute of Bioenergy and Bioprocess Technology have introduced “process ramanomics,” a single‑cell Raman spectroscopy workflow that monitors beer fermentation in real time. By capturing Raman fingerprints from individual yeast cells, the method accurately predicts 19 extracellular...
This is happening because scientific research in the US is done by hand at the lab bench. China is very good at having lots of skilled, manual labor. We need to move our paradigm for doing science off the lab...
Johnson & Johnson reported that Tecvayli (teclistamab) monotherapy cut overall survival risk by 40% in the MajesTEC‑9 trial for patients who had received one to three prior lines of therapy. The same study showed a 71% reduction in progression‑free survival...
The FDA announced it will postpone its action date for Eli Lilly’s oral obesity drug orforglipron to April 10, 2026, extending the review timeline for the medication. The agency also delayed decisions for three other Commissioner’s National Priority Voucher recipients—Sanofi’s Tzield, Disc Medicine’s...
Arizona‑based Strive Compounding Pharmacy has filed an antitrust lawsuit in Texas against Eli Lilly and Novo Nordisk, accusing the two giants of coordinating with telehealth firms to block compounders from filling GLP‑1 prescriptions. The complaint alleges that the pharma companies restrict payment...
Jazz Pharmaceuticals sold a priority review voucher for $200 million, the highest price in nearly a decade, during its J.P. Morgan Healthcare Conference presentation. The voucher stemmed from the FDA’s August 2025 approval of Modeyso, a rare‑brain‑tumor drug acquired through Chimerix. While...
Rare‑disease therapeutics dominated day three of J.P. Morgan Healthcare, with five companies outlining 2026 roadmaps. Rocket Pharmaceuticals announced it will resume dosing three Danon disease patients in the first half of 2026 after an FDA hold, while also awaiting a...
Is there a single person feeding La Lettre fake biotech takeover tips, or is this a group effort? The stock manipulation is brazen. First, we learn all the $ABVX $LLY French Ministry speculation was fake, now today it's $SNY $OCUL...
Ocugen announced positive interim Phase 2 data for its geographic atrophy (GA) gene therapy, a leading cause of vision loss in age‑related macular degeneration. The trial, though limited to a small patient cohort, demonstrated measurable improvements in retinal function and...
Cellares has signed a long‑term lease for a 9,741 m² site at Leiden Bio Science Park, designating it as its European headquarters and a new IDMO Smart Factory. The facility will host the company’s automated Cell Shuttle manufacturing platform and Cell...
Novartis has sent an open letter to governments in the EU, Canada and Japan warning that fragmented regulation, unpredictable pricing and blunt cost‑control tools are causing Europe to lose life‑science ground to the United States and China. The company, together...
Researchers have unveiled a new memristive architecture that dramatically improves human‑machine interfaces (HMIs). The technology leverages analog resistance states to store and process data directly at the sensor level, cutting latency and power draw. Early prototypes demonstrate real‑time pattern recognition...
Johnson & Johnson announced that its bispecific antibody Tecvayli (teclistamab) achieved a statistically significant overall survival benefit in a Phase 3 trial evaluating an earlier‑line setting for multiple myeloma. The study reported a hazard ratio of 0.68 for death and extended...
TikTok and other platforms are fueling a surge in DIY Botox, where consumers purchase unapproved botulinum toxin online and self‑inject it. In late 2025 the FDA issued warning letters to 18 websites selling counterfeit or misbranded products, citing adverse events...
The paper examines epigenetic regulation of senescence in CD8+ T cells from younger and older donors, revealing that the senescent state, rather than chronological age, drives the majority of epigenomic and transcriptional shifts. Approximately 40% of detectable transcription factors are...
Researchers discovered that transforming growth factor‑beta (TGF‑β) signaling in microglia acts as a protective checkpoint for myelin integrity in the aging spinal cord. In aged mice, the dorsal column showed pronounced myelin degeneration alongside heightened TGF‑β activity in resident microglia....
The article outlines the gold standard for spectroscopy in pharmaceutical labs, emphasizing that precise colour and turbidity measurements underpin brand integrity, product identification, and patient safety. It profiles six manufacturers—HunterLab, Shimadzu, PerkinElmer, Thermo Fisher Scientific, Agilent, and Mettler Toledo—detailing flagship...
Medical device startup MARS Bioimaging announced a $15 million Series A round, led by Pacific Channel. The financing was delivered in two tranches—$7.6 million initially and $7.4 million later in 2026. The capital will accelerate deployment of its portable spectral photon‑counting CT scanners across...
Oxford BioMedica, a UK contract development and manufacturing organisation specialising in cell and gene therapies, disclosed an unsolicited cash approach from Stockholm‑listed private‑equity group EQT. The news sent the shares up 15% intraday and over a third higher year‑to‑date, reflecting...
Researchers at MIT have identified intelectin‑2, a lectin produced in the gut, as a broad‑spectrum antimicrobial protein. The molecule binds galactose residues on both mucins and bacterial membranes, reinforcing the mucus barrier and trapping microbes. Trapped bacteria eventually disintegrate, showing...
The Novo Nordisk Foundation announced a commitment of 5.5 billion Danish kroner (approximately $857 million) to the BioInnovation Institute, a life‑science and deep‑tech incubator, with funding extending through 2035. The pledge aims to bolster the institute’s capacity to nurture early‑stage biotech and...
At the J.P. Morgan Healthcare Conference, venture capitalists highlighted a tightening funding environment for early‑stage biotech firms, driven by a hyper‑concentration of capital among a few investors. VCs now scrutinize founder and CEO attributes, emphasizing regulatory know‑how, market insight, and...
Big Pharma is accelerating domestic manufacturing hiring as 2026 begins, highlighted by Johnson & Johnson’s plan to add 500 jobs at a new North Carolina plant and AbbVie’s $100 billion ten‑year commitment to U.S. R&D and capital projects. The surge creates...
A recent Buck Institute study analyzed blood from the four‑person Axiom 2 crew, revealing that a 10‑day spaceflight accelerated epigenetic age by roughly 1.9 years by day 7. Serial sampling showed the acceleration reversed after landing, with older astronauts returning to baseline and...
Researchers have identified a new class of natural products called chlocarbazomycins that act as potent antagonists of the adenosine A1 receptor. In preclinical assays, these compounds bind with nanomolar affinity and demonstrate functional activity, lowering heart rate and improving neuronal...
Researchers have demonstrated that incorporating N1‑methylpseudouridine (m1Ψ) into synthetic mRNA reshapes ribosomal translation dynamics. High‑resolution ribosome profiling shows accelerated elongation rates and altered codon‑specific pausing compared with unmodified uridine. The modification also dampens innate immune sensing, leading to higher protein...
China’s JNBY Group introduced a plant‑based faux‑fur vest for its Croquis menswear line, marking the first large‑scale retail rollout of BioFluff’s Savian material. The collaboration leverages JNBY’s vertically integrated network of over 2,100 stores, allowing the eco‑fur product to reach...
Yep. Truth from @zavaindar Though unlike cars, phones, solar panels, etc, US controls the biotech market because we are only ones who pay fair price for drugs (70% of profits originate from US consumers). So we can stop...
New @ScienceMagazine A thoughtful and comprehensive review on how multimodal AI can transform mental health, with emphasis on a patient-centric approach "The successful translation of AI into clinical practice will require robust validation" https://t.co/xSACrFI0tW https://t.co/8jiV6P1vdj
Researchers have identified the ubiquitin ligase KLHL6 as a critical driver of CD8+ T‑cell resistance in cancer. KLHL6 promotes degradation of the inhibitory receptor PD‑1, thereby sustaining T‑cell activation within the tumor microenvironment. In mouse models, genetic ablation or pharmacologic...
Qilu appears to be aping $JNJ in trispecific T-cell engagers. First BCMA x GPRC5D, now CD79b x CD20. Via @ApexOnco -> https://t.co/d4pBcl0MuF
$IBRX Anktiva q/q sales growth slowed, cash balance decreased. How much dilutive cash did the company raise from its adjusted ATM in January? https://t.co/UTKcVOAs4x Classic: Issue lots of press releases, pump stock higher, sell stock.
The ENIGMA Bipolar Disorder Working Group pooled MRI data from 6,729 participants to examine how psychotropic medications influence subcortical brain volumes in bipolar disorder. Lithium use was associated with larger hippocampal and thalamic volumes, whereas antipsychotics and valproate correlated with...
Non-negative matrix factorization is a commonly used technique in genomics data analysis. Read my tutorial on how you can use it for single-cell RNAseq data https://t.co/2SA1JdLfkT https://t.co/6kI1gcqyOe
Bioinformatics is a fast-moving field, how to stay current? 👇 The answers are different in different times. I read Stephen's post around 2012 and I hopped on Twitter; followed a bunch of bioinformaticians, Journals and professors. It changed my career trajectory. https://t.co/QYV5vKFQgP
Recent genomic studies reveal that somatic mosaic loss, particularly mosaic chromosomal alterations, is significantly associated with early‑onset schizophrenia and bipolar disorder. Analyses of over 12,000 schizophrenia cases identified recurrent somatic copy‑number variants disrupting NRXN1 and ABCB11, while prenatal mutational signatures...
1/ I've analyzed dozens of single-cell datasets. I still google "Seurat clustering parameters" every single time. Last week I tried something different. I asked Claude Code to explain my clustering results instead of just generating them. https://t.co/AMQpheqhYC
The reckless human embryo genome editor, He Jiankui, known as China's Dr. Frankenstein, is back at it. "People were not yet ready to accept what I was doing." We're still not. https://t.co/UYIwWj0qf1
The latest generation of intracellular PROTACs now offers precise spatial activation, tunable persistence, and expanded ubiquitin‑ligase recruitment, addressing the pharmacokinetic and toxicity hurdles of earlier candidates. Chinese research groups have pioneered formulations that release the degrader only within target cells...
So far I have finished writing two comprehensive 🧵which covered both $BEAM & $PRME #JPM26’s presentations. $XBI Before I continue to write additional #JPM2026🧵’s I’m interested in hearing your thoughts about which company - if at all - would you want...
Not good to see the rise in p-tau181, a blood biomarker of brain inflammation tied to increased risk of Alzheimer's disease, in a prospective cohort (mean age 56 years) with #LongCovid and neurological symptoms https://t.co/XTd5qeN24e @eBioMedicine https://t.co/B1fkhoydFI
A 5★ new review of the GLP-1 drugs, what they have achieved, and where the field is headed with so many new molecules and combinations @TheLancet https://t.co/E1Xa15fk1q https://t.co/Jjmw01L5KM
